Article Information
History
- November 8, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maura Malpetti1,
- Rogier A. Kievit2,
- Luca Passamonti1,3,
- P. Simon Jones1,
- Kamen A. Tsvetanov1,
- Timothy Rittman1,
- Elijah Mak4,
- Nicolas Nicastro4,5,
- W. Richard Bevan-Jones4,
- Li Su4,
- Young T. Hong1,
- Tim D. Fryer1,
- Franklin I. Aigbirhio1,
- John T. O’Brien4,6,* and
- James B. Rowe1,2,6,*,†
- 1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- 2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
- 3Institute of Molecular Bioimaging and Physiology, National Research Council, Milano, Italy
- 4Department of Psychiatry, University of Cambridge, Cambridge, UK
- 5Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland
- 6Cambridge University Hospitals NHS Trust, Cambridge, UK
- ↵†Corresponding Author:
Prof. James B. Rowe, Department of Clinical Neurosciences, University of Cambridge, Herchel Smith Building, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge CB2 0SZ, Email: james.rowe{at}mrc-cbu.cam.ac.uk
Posted November 08, 2019.
Microglial activation and tau burden predict cognitive decline in Alzheimer’s Disease
